Home › Therapeutic areas › Oncology › Gastroesophageal Junction Cancer

Gastroesophageal Junction Cancer (2 companies)

Companies with an active program in Gastroesophageal Junction Cancer.

Ticker Company Therapeutic areas Programs Lead stage Programs
XNCR Xencor ImmunologyNeurology+1 Rare 1 Approved 28
ZYME Zymeworks OncologyRespiratory 1 Approved 11